{"transactions":[{"id":940692,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-01-12T20:50:58.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":7700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs vest on January 12, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs vest on January 12, 2027."}],"balance_after":7700,"derivative":{"exercise_date":"2027-01-12","expiration_date":"2027-01-12","underlying":"Common Stock","underlying_shares":7700},"source":{"system":"sec-edgar","filing":"0001193125-26-010852","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1761518/000119312526010852/ownership.xml","form_type":"4"}},{"id":940691,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-12T20:50:58.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on January 12, 2027."}],"balance_after":11500,"derivative":{"exercise_price":23.16,"exercise_date":"2027-01-12","expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001193125-26-010852","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761518/000119312526010852/ownership.xml","form_type":"4"}},{"id":1333404,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-12T18:15:29.000Z","date":"2024-12-10","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 10, 2024."}],"balance_after":31000,"derivative":{"exercise_price":13.06,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0000950170-24-135948","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761518/000095017024135948/ownership.xml","form_type":"4"}},{"id":1717389,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T17:48:30.000Z","date":"2023-12-07","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 7, 2023."}],"balance_after":37000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0000950170-23-069126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761518/000095017023069126/ownership.xml","form_type":"4"}},{"id":1840780,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-30T20:05:19.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest in 36 equal monthly installments starting one month after grant date of June 30, 2023."}],"balance_after":50000,"derivative":{"exercise_price":8.64,"expiration_date":"2033-06-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-23-031230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761518/000095017023031230/ownership.xml","form_type":"4"}},{"id":1944188,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-20T22:43:33.000Z","date":"2023-03-16","kind":"sale","planned":false,"acquired":false,"shares":1748,"price":1.9791,"value":3459.4668,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,875 restricted stock units."}],"balance_after":38224,"source":{"system":"sec-edgar","filing":"0001140361-23-012617","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036123012617/form4.xml","form_type":"4"}},{"id":2203766,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:08:47.000Z","date":"2022-07-20","kind":"sale","acquired":false,"shares":3949,"price":1.4224,"value":5617.0576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to a PSU of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,500 restricted stock units."}],"balance_after":39972,"source":{"system":"sec-edgar","filing":"0001567619-22-014296","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014296/doc1.xml","form_type":"4"}},{"id":2203765,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-21T20:08:47.000Z","date":"2022-07-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Performance Stock Units (\"PSUs\") initially granted on October 24, 2021 that were subject to a performance-based vesting condition. The first milestone vesting condition was determined to be satisfied upon which 50% of the PSUs vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,500 restricted stock units."}],"balance_after":43921,"source":{"system":"sec-edgar","filing":"0001567619-22-014296","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922014296/doc1.xml","form_type":"4"}},{"id":2411400,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T21:50:45.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 2, 2022 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":135000,"derivative":{"exercise_price":4.13,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001567619-22-002522","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002522/doc1.xml","form_type":"4"}},{"id":2411399,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-04T21:50:45.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/4th of the RSUs vest annually on March 15 of each year, with the first 1/4th vesting on March 15, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 22,500 RSUs."}],"balance_after":28921,"source":{"system":"sec-edgar","filing":"0001567619-22-002522","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761922002522/doc1.xml","form_type":"4"}},{"id":2534389,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Performance Stock Units (PSUs)","published_at":"2021-10-26T20:25:23.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. 50% of the PSUs vest upon achievement of a certain performance-based milestone within 1 year from grant date and 50% of the PSUs vest upon achievement of a certain performance-based milestone within 2 years from grant date."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001567619-21-018717","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018717/doc1.xml","form_type":"4"}},{"id":2534388,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-26T20:25:23.000Z","date":"2021-10-24","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from October 24, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":40000,"derivative":{"exercise_price":5.34,"expiration_date":"2031-10-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-21-018717","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921018717/doc1.xml","form_type":"4"}},{"id":2677100,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-06-08T17:08:34.000Z","date":"2021-05-31","kind":"grant","acquired":true,"shares":3320,"price":6.086,"value":20205.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":6421,"source":{"system":"sec-edgar","filing":"0001567619-21-011807","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921011807/doc1.xml","form_type":"4"}},{"id":2818998,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T22:01:21.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from February 26, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":100000,"derivative":{"exercise_price":7.85,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-21-005399","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761921005399/doc1.xml","form_type":"4"}},{"id":2954880,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-07T21:57:42.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":3101,"price":6.392,"value":19821.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"3,101 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":3101,"source":{"system":"sec-edgar","filing":"0001567619-20-020706","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920020706/doc1.xml","form_type":"4"}},{"id":3195051,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-25T20:09:40.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Inducement Option Award will vest and become exercisable as to 25% of the total number of shares subject to the option on March 23, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date."}],"balance_after":350000,"derivative":{"exercise_price":4.93,"expiration_date":"2030-03-22","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001567619-20-006996","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920006996/doc1.xml","form_type":"4"}},{"id":3388615,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T19:30:30.000Z","date":"2019-10-22","kind":"disposition_to_issuer","acquired":false,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 16, 2019, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with H. Lundbeck A/S (\"Lundbeck\"), Lundbeck LLC and Violet Acquisition Corp., a wholly owned subsidiary of Lundbeck (\"Purchaser\").  On October 22, 2019 (the \"Effective Time\"), Purchaser merged with and into the Issuer pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Lundbeck."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of December 12, 2018 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option, whether or not vested, were cancelled and converted into the right to receive both (i) a cash payment equal to (A) the excess, if any of (x) $18.00 over (y) the Exercise Price per share listed in Column 2 of Table II of this Form 4, multiplied by (B) the total number of shares listed in Column 5 of Table II of this Form 4, and (ii) one non-transferable contingent value right for each share subject to this option, which represents the contractual right to receive up to an additional $2.00 per share upon achievement of a milestone."}],"balance_after":0,"derivative":{"exercise_price":11.5,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001209191-19-053952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919119053952/doc4.xml","form_type":"4"}},{"id":3730611,"issuer":{"id":154258,"kind":"organization","name":"ALDER BIOPHARMACEUTICALS INC","symbol":"ALDR"},"owners":[{"id":69497,"kind":"person","name":"Campoy Carlos","position":1,"cik":"0001761518","reported_name":"Campoy Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T17:20:34.000Z","date":"2018-12-12","kind":"grant","acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of December 12, 2018 (the \"Vesting Commencement Date\") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date."}],"balance_after":270000,"derivative":{"exercise_price":11.5,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001209191-18-062781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1423824/000120919118062781/doc4.xml","form_type":"4"}}]}